News

Healthcare Dive6h
Evernorth reaches deals with Novo Nordisk, Eli Lilly to cap GLP-1 copays
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
Fierce Healthcare1d
New Evernorth program to cap out-of-pocket costs for Wegovy, Zepbound at $200
Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...
Pharmaceutical Technology on MSN15h
Wegovy and Zepbound costs capped at $200 in new Evernorth programme
Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...
Managed Healthcare Executive12h
Evernorth to Cap Out-of-Pocket Cost for Wegovy and Zepbound at $200
Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.
Modern Healthcare1d
Cigna debuts GLP-1 copay cap
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...
Cigna takes different approach with GLP-1s, more favorable for Eli Lilly
Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss medications at $200 per month, in a move analysts say is more favorable for Eli Lilly ...
StockStory.org on MSN6h
Why Hims & Hers Health (HIMS) Stock Is Falling Today
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna ...